Accordingly, Ahr ligands are found decreased in the microbiota of IBD patients, especially in the individuals with IBD-associated single-nucleotide polymorphism within CARD9 (rs10781499), suggesting microbiota–Ahr ligand axis may be a therapeutic target of colitis in humans (92). Here, AHR is linked to inflammatory bowel disease.